Heart Failure Clinical Trials UK: Advancing the Future of Cardiac Treatment
For people living with heart failure, established treatments can help control symptoms, reduce pressure on the heart and improve everyday life. However, these treatments cannot always repair the heart muscle that has already been damaged. This is why clinical research remains so important.
Heart Cells Foundation supports pioneering research into the potential use of a patient’s own adult stem cells to help damaged hearts. Through carefully managed Heart Failure Clinical Trials UK, researchers are working to understand whether regenerative medicine could provide new options for people whose condition has not responded sufficiently to conventional care.
Why Are Heart Failure Clinical Trials Needed?
Heart failure occurs when the heart is unable to pump blood around the body as effectively as it should. It does not mean that the heart has stopped working, but it may struggle to meet the body’s needs.
People with heart failure may experience breathlessness, severe tiredness, swollen legs, reduced mobility and difficulty completing ordinary daily activities. The condition can develop following a heart attack, because of damage to the heart muscle or as a result of another medical condition.
Medicines, pacemakers, implanted devices, lifestyle changes and surgery can all play an important role in treatment. Clinical trials examine whether additional approaches may also be safe and beneficial.
By supporting clinical research into heart failure, Heart Cells Foundation is helping specialists explore whether adult stem cells could encourage repair, improve blood flow or support weakened areas of the heart.
What Happens During a Heart Failure Clinical Trial?
Every clinical trial follows an agreed research plan. This is designed to protect participants while allowing clinicians to gather meaningful and reliable evidence.
The process may begin with an assessment of the patient’s diagnosis, medical history, current treatment and general health. Researchers must determine whether the person meets the trial’s specific eligibility criteria.
Where adult stem cell treatment forms part of the study, cells may be collected from the patient’s own bone marrow. They are then prepared by specialists before being delivered to carefully selected areas of the heart.
Participants are monitored before, during and after treatment. Follow-up may include medical examinations, scans, blood tests, exercise assessments and questions about symptoms or quality of life. This monitoring helps researchers understand both potential benefits and possible risks.
The Foundation’s work supports patient-centred cardiac research in which safety, responsible trial design and long-term follow-up remain essential.
The Potential of Adult Stem Cell Research
Adult stem cells are sometimes described as part of the body’s natural repair system. Researchers are investigating whether cells taken from the patient could help stimulate healing processes within damaged heart tissue.
This does not mean that stem cells are a proven cure for heart failure. The treatment remains an evolving area of medicine, and further evidence is needed before it could become routinely available to patients.
Clinical trials are designed to provide that evidence. They allow researchers to measure changes in heart function, symptoms, physical ability and wellbeing over time.
Through its support for adult stem cell research, Heart Cells Foundation is helping clinicians move beyond theory and examine what regenerative medicine may realistically offer people living with serious heart disease.
Why Heart Cells Foundation?
Heart Cells Foundation has a specialist and clearly defined mission. Its work is focused on developing regenerative approaches to heart disease rather than dividing funding across a wide range of unrelated conditions.
The Foundation supports work connected with Barts Health NHS Trust and St Bartholomew’s Hospital in London. Barts Health has reported that approximately 500 patients had received this form of stem cell therapy through early-phase clinical trials and a compassionate-use programme by December 2025.
This combination of charitable funding, specialist medical knowledge and direct experience with patients places the Foundation in a strong position to help advance the research responsibly.
By choosing to support heart failure research, donors and fundraisers can help meet the costs associated with specialist clinicians, laboratory preparation, hospital facilities, participant monitoring and detailed analysis of trial results.
Putting Patients Before Promises
People searching for Heart Failure Clinical Trials UK may be doing so at an extremely difficult point in their lives. It is therefore important that information about experimental treatments is presented clearly and honestly.
Participation in a trial cannot guarantee an improvement. Not every patient will be eligible, and any potential treatment will have limitations and risks that must be discussed with the clinical team.
Heart Cells Foundation promotes responsible heart stem cell research rather than unrealistic promises. Patients should never stop prescribed medicines or make changes to their current care without first speaking to their cardiologist or healthcare professional.
Clinical trials should complement high-quality medical care, not replace it.
Helping Research Move Forward
Medical progress depends on long-term commitment. A promising early study must be followed by larger trials, careful comparison and continued monitoring before a treatment can be considered for wider use.
Charitable funding can make this possible. Individuals, families, businesses and community groups can help fund future heart treatments through donations, events, sponsored challenges, corporate partnerships and legacy giving.
Supporters can also browse heart research updates to follow developments and learn more about the people behind the work. News and community activity are shared through the Foundation’s Facebook page.
Heart Failure Clinical Trials Across the United Kingdom
Heart failure affects people throughout England, Scotland, Wales and Northern Ireland. NIHR reported in 2024 that around one million people in the UK were living with the condition, highlighting the continuing need for better treatments and improved quality of life.
The United Kingdom has an established clinical-research network supported by the NHS, specialist hospitals, universities, charities and patients who volunteer to take part in studies.
Heart Cells Foundation contributes to this national effort by supporting pioneering UK heart research in London, with the long-term ambition of helping effective regenerative treatments become accessible to suitable patients more widely.
For enquiries about the Foundation’s research, fundraising activities or patient information, call 020 7935 5351 or contact Heart Cells Foundation using the details provided on this website.
Frequently Asked Questions
What are heart failure clinical trials?
They are carefully controlled studies that assess new ways to diagnose, manage or treat heart failure.
Can anyone join a stem cell clinical trial?
No. Participants must meet specific medical and research criteria determined by the clinical team.
Are stem cells a proven cure for heart failure?
No. Adult stem cell treatment remains under investigation and cannot be presented as a guaranteed cure.
Will I need to continue my usual medication?
Usually, yes. Never change prescribed treatment unless your healthcare team advises you to do so.
How can I support the clinical research?
You can donate, fundraise, take part in an event, create a corporate partnership or consider leaving a legacy.
Explore Heart Stem Cell Research, Treatment and Support
Discover more about cardiac stem cell therapies, stem cell therapy for heart failure, heart failure stem cell treatment in the UK, regenerative medicine for heart failure and heart repair treatment with stem cells. You can also explore information about stem cell clinical trials for heart failure in the UK, the Phase III stem cell trial for heart failure, heart failure clinical trials in the UK, compassionate treatment for heart failure and heart stem cell treatments in London. Learn whether stem cells can reverse heart damage, stem cells can repair the heart, how stem cell therapy for heart failure works, how adult stem cells may support heart repair and the potential of stem cell treatment after a heart attack. Supporters can also find out more about the Foundation as a heart stem cell research charity in the UK, fund cardiac stem cell research, leave a gift in their will to a heart charity or form a corporate partnership with a heart charity.